STABILIZED PRE-FUSION RSV FB ANTIGENS

The present invention provides stable pre-fusion respiratory syncytial virus (RSV) FB proteins, nucleic acid molecules and vectors encoding such proteins, and compositions comprising said proteins, nucleic acid molecules and/or vectors, and uses thereof for the prevention and/or treatment of RSV inf...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: LANGEDIJK Johannes Petrus Maria, BAKKERS Mark Johannes Gerardus, RITSCHEL Tina
Format: Patent
Sprache:eng ; spa
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The present invention provides stable pre-fusion respiratory syncytial virus (RSV) FB proteins, nucleic acid molecules and vectors encoding such proteins, and compositions comprising said proteins, nucleic acid molecules and/or vectors, and uses thereof for the prevention and/or treatment of RSV infection. La presente invención proporciona proteínas FB del virus respiratorio sincitial (RSV) prefusión estables, moléculas de ácido nucleico y vectores que codifican tales proteínas, y composiciones que comprenden tales proteínas, moléculas y/o vectores de ácido nucleico, y usos de estas para la prevención y/o tratamiento de la infección por RSV.